PureIMS Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$4.81M
- Investors
-
6
PureIMS General Information
Description
Manufacturer of dry powder inhalation products designed to offer effective pulmonary administration. The company's dry powder formulation equipment is broken up into small particles appropriately sized for deep lung deposition, which enables patients with diseases like cystic fibrosis, bronchiectasis, tuberculosis, Parkinson's Disease, or anaphylaxis to inhale and avoid the need for injection, enabling strong local pulmonary drug effects or extremely short onset of action in case of systemic applications.
Contact Information
Website
www.pureims.comCorporate Office
- Ceintuurbaan Noord 152
- 9301 NZ Roden
- Netherlands
Corporate Office
- Ceintuurbaan Noord 152
- 9301 NZ Roden
- Netherlands
PureIMS Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | $4.81M | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC | 03-Apr-2023 | Completed | Clinical Trials - Phase 1 | |||
| 4. Seed Round | Completed | Clinical Trials - Phase 1 | ||||
| 3. Later Stage VC | 26-Apr-2019 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 12-Oct-2017 | Completed | Clinical Trials - Phase 1 | |||
| 1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PureIMS Comparisons
Industry
Financing
Details
PureIMS Competitors (4)
One of PureIMS’s 4 competitors is MannKind, a Formerly VC-backed company based in Danbury, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MannKind | Formerly VC-backed | Danbury, CT | ||||
| Pulmatrix | Formerly VC-backed | Framingham, MA | ||||
| Savara | Formerly VC-backed | Yardley, PA | ||||
| Insmed | Formerly VC-backed | Bridgewater, NJ |
PureIMS Patents
PureIMS Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4683692-A1 | Breath actuated dry powder inhaler | Pending | 20-Mar-2023 | ||
| WO-2024196247-A1 | Breath actuated dry powder inhaler | Inactive | 20-Mar-2023 | ||
| JP-2026509561-A | Respiratory-operated dry powder inhaler | Pending | 20-Mar-2023 | A61M15/0043 |
PureIMS Signals
PureIMS Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boost-Up Groningen | Venture Capital | Minority | ||
| Carduso Capital | Venture Capital | Minority | ||
| University of Groningen | University | |||
| European Union | Government | |||
| IMDS | Corporation | Minority |
PureIMS FAQs
-
When was PureIMS founded?
PureIMS was founded in 2014.
-
Where is PureIMS headquartered?
PureIMS is headquartered in Roden, Netherlands.
-
What is the size of PureIMS?
PureIMS has 10 total employees.
-
What industry is PureIMS in?
PureIMS’s primary industry is Therapeutic Devices.
-
Is PureIMS a private or public company?
PureIMS is a Private company.
-
What is PureIMS’s current revenue?
The current revenue for PureIMS is .
-
How much funding has PureIMS raised over time?
PureIMS has raised $8.78M.
-
Who are PureIMS’s investors?
Boost-Up Groningen, Carduso Capital, University of Groningen, European Union, and IMDS are 5 of 6 investors who have invested in PureIMS.
-
Who are PureIMS’s competitors?
MannKind, Pulmatrix, Savara, and Insmed are competitors of PureIMS.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process